- Home
- CDT vs CSCI Comparison
CDT vs CSCI Comparison
Compare CDT & CSCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDT
- CSCI
- Stock Information
- Founded
- CDT 2019
- CSCI 1990
- Country
- CDT United States
- CSCI Canada
- Employees
- CDT 7
- CSCI N/A
- Industry
- CDT Biotechnology: Pharmaceutical Preparations
- CSCI
- Sector
- CDT Health Care
- CSCI
- Exchange
- CDT Nasdaq
- CSCI NYSE
- Market Cap
- CDT 9.0M
- CSCI 11.1M
- IPO Year
- CDT N/A
- CSCI 1996
- Fundamental
- Price
- CDT $0.07
- CSCI $2.50
- Analyst Decision
- CDT
- CSCI
- Analyst Count
- CDT 0
- CSCI 0
- Target Price
- CDT N/A
- CSCI N/A
- AVG Volume (30 Days)
- CDT 16.2M
- CSCI 4.1K
- Earning Date
- CDT 02-14-2025
- CSCI 11-12-2024
- Dividend Yield
- CDT N/A
- CSCI N/A
- EPS Growth
- CDT N/A
- CSCI N/A
- EPS
- CDT N/A
- CSCI N/A
- Revenue
- CDT N/A
- CSCI $4,834,000.00
- Revenue This Year
- CDT N/A
- CSCI N/A
- Revenue Next Year
- CDT N/A
- CSCI N/A
- P/E Ratio
- CDT N/A
- CSCI N/A
- Revenue Growth
- CDT N/A
- CSCI N/A
- 52 Week Low
- CDT $0.06
- CSCI $2.50
- 52 Week High
- CDT $5.44
- CSCI $11.10
- Technical
- Relative Strength Index (RSI)
- CDT 40.15
- CSCI N/A
- Support Level
- CDT $0.08
- CSCI N/A
- Resistance Level
- CDT $0.09
- CSCI N/A
- Average True Range (ATR)
- CDT 0.01
- CSCI 0.00
- MACD
- CDT -0.00
- CSCI 0.00
- Stochastic Oscillator
- CDT 27.18
- CSCI 0.00
About CDT Conduit Pharmaceuticals Inc.
Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being, prioritized by leading biopharmaceutical companies in order to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready in autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.
About CSCI COSCIENS BIOPHARMA INC
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology.